ArticlePDF Available

Acute angle closure glaucoma presenting in a young patient after administration of paroxetine [14]

Authors:



    
     
      
   
  
  
     


 
    
   
  
  

   
  

  
 
 


    
    
    
  
  
 
References
   
  
  

    
   

 
   

    
     
      

    
     

           
    
     
    


 
 
    
   
 
 

   
 
  
 
  
    
  
    
  
  


   
 

 
   



 
    
Case report

    


  


      
  
   
 


   

  

 
  


   
  
   
  

   

   
    
    
 
  
 

   

 

 
 

     


   
   
   
 
    
 
Comment
  
 
  
   

  
    
    
  
    


  

 


  

 

 


   
     


   

 


   
   

  

 
     

   
    
   
    
   
    
     
    

References
       
   
      
    

    
    
 


      
     
    
  
       

       
     
 
        
    
     
     
   

     
      
     

        
  
  
 
 
  
  
   
  
     

    
  
   
  
   
 
  
  



      

 

       
   
   
      
   
   
   
   
Case r
ort
   

   
      
     
         
     
     
  
     

      


   
     
     

    
      
     
    
     
     
       


     
   
   
    
   
     
       
         
     
   
     
      
 
       
     
      
+30"
         
     
  
... In published case reports, AAC associated with SSRIs administration was characterized by variety clinical presentation. The most frequently presented symptoms include blurred vision, eye pain, redness or discomfort in the eye, headache, haloes around light sources, photophobia, nausea, and vomiting [17][18][19][20][21][22], It is worth emphasizing that in two reported cases, three days before the onset of AAC, heralding symptoms such as ocular pain and blurred vision were observed [21,23]. ...
... An anterior segment examination using a slit lamp, or with the use of ultrasound biomicroscopy (UBM), assessment of pupil reactivity to light, visual acuity test as well as fundus examination with the evaluation of optic discs are also performed [14,24]. Frequent findings in the ophthalmological examination included decreased visual acuity, corneal oedema, fixed and mid-dilated pupils, shallow anterior chamber, increased IOP (usually up to 60-80 mmHg), closure of the iridocorneal angle, iris plateau configuration, and cataractous changes in the lens [17,[19][20][21]25]. In some cases, the optic disc may be swollen [14]. ...
... Fifteen cases of AAC associated with SSRIs have been reported to date (Table 3) [17][18][19][20][21][22][25][26][27][53][54][55][56][57][58]. Interestingly, they include all SSRIs drugs. ...
Article
Full-text available
Acute angle closure (AAC) is a relatively rare but serious ophthalmological condition in which early diagnosis and intraocular pressure (IOP) -lowering treatment play a key role in prognosis. The aim of this review is to present current understanding of the pathophysiology, symptoms, diagnosis, potential mechanisms as well as management of AAC associated with the use of selective serotonin reuptake inhibitors (SSRIs). In most cases, AAC in individuals receiving SSRIs occurs in the pupillary block mechanism, secondary to SSRI-induced mydriasis. However, SSRIs may also cause uveal effusion and, consequently, iridocorneal angle closure. Other factors such as impaired metabolism and elimination of SSRIs, individual genetic conditions, as well as inhibition of SSRIs metabolism due to the effects of other drugs used may also promote AAC.
... To our knowledge, only five cases of drug-associated APAC with plateau iris have been reported: a 40-year-old male receiving paroxetine for depression [9]; a 54-year-old female treated with paroxetine [10]; a 36year-old female treated with topiramate [11]; a 60-year-old male treated with acetazolamide [12]; and a 45year-old female treated with aripiprazole [13]. Table 1 summarizes these past cases and the current case. ...
... Table 1 summarizes these past cases and the current case. One eye of one of these previous cases underwent trabeculectomy and had a good final visual outcome [11], while seven eyes of four cases underwent laser peripheral iridotomy [9,[11][12][13]. Thus, the case reported here is the first to have undergone clear-lens extraction for drug-associated APAC with plateau iris. ...
Article
Full-text available
Acute primary angle closure (APAC) is rare in young adults (those under approximately 40 years old) and pregnant women. Here, we report the case of a 37-year-old primigravid woman with APAC caused by plateau iris after the use of ritodrine (a β2 stimulator) that was successfully resolved by clear-lens extraction five months after delivery. The patient presented with pain in her right eye after ritodrine infusion for threatened premature labor at 23 weeks of gestation. Her visual acuity was 20/40, and her intraocular pressure (IOP) was 31 mmHg in her right eye. The patient was diagnosed as having APAC with plateau iris based on ultrasound biomicroscopy (UBM) findings of irido-angle touch, anterior dislocation of the ciliary process, and an absent ciliary sulcus. The effectiveness of treatment with pilocarpine eyedrops was limited, and argon laser peripheral iridoplasty did not succeed in reducing IOP. An immediate resolution was achieved with clear-lens extraction. IOP has since stayed within 14-16 mmHg without any medication for seven years. This is the first reported case of APAC complicated with plateau iris after ritodrine use in a pregnant woman. This condition is rare in young adults, making it difficult to diagnose; however, UBM can be of great help. In this case, clear-lens extraction led to a successful outcome. Our case suggests that attention should be paid to drug associations when APAC occurs with plateau iris.
... AACG is an ocular emergency and requires immediate treatment. Rapid diagnosis, immediate intervention, and referral can have profound effects on patient outcome and morbidity (8). Studies revealed that the probability of glaucoma-especially AACG-is higher with SSRIs that have a stronger norepinephrine and serotonin reuptake inhibitor (17). ...
... The safety review focused on the 23 drugs-antidepressant medications-available in Canada.The results showed a 5.8-fold increased risk of AACG at the beginning of the use of SSRIs. However,theresults were limited to Taiwan's population, known as a high-risk group;the visual effects of medication use other than antidepressants were notassessed,which may be a mainprobable confounder (6).Studies on the effects of the long-term use of SSRIs on the level of intraocular pressure are very limited (17).The findings of the retrospective cohort study by Chen et al. in 2015 showed that more than a year'sconsumption of SSRIs was not accompanied with an increased risk of primary openangle glaucoma (POAG) or primary angle-closure glaucoma (PACG) in patients with depression (8).In contrast, the recent study revealed that the probability of glaucoma in patients younger than 65 years, treated with SSRIs at doses equal to or higher thanone defined daily dose for one year or more, is significantly higher than that of the control group (17). According to an analysis of the related literatures,the dataon the association between chronic consumption of SSRIs and changes in IOP level and optic nerve head function in patients without underlying eye and noneye diseases are limited.Their results are also associated with controversies (7, 9-15, 18, 19).Now, it is unclear whether the risk of ocular complications of SSRIs is limited to high-risk patients, such as a family history of the condition, migraines, high blood pressure, obesity, old age, female sex, Eskimo or Asian ethnicity, or whether itoccurs in all cases (14,16).To the best of our knowledge,no prospective studyhasbeen reported so far to assess the trend of intraocular pressure andcup-to-disc ratio (CDR) in patients treated with SSRIs and without underlying eye and non-eye diseases.This study is the first one to assess the effect of sertraline on the level of IOP and CDRin patients with anxiety disorders or mixed anxiety and depressive disorder or major depressive disorder aged between 20 and 40 years old with no underlying eye diseaseswho have beenunder dailytreatment withsertralinefor three months. ...
... Mydriasis, elevated intraocular pressure (IOP), and angle closure glaucoma (ACG) are wellknown ocular side effects of SSRIs 3,4, [8][9][10][11][12][13][14][15][16][17][18] . Branch retinal vein occlusion, central retinal vein occlusion, maculopathy, and cataracts are also ocular side effects [5][6][7][19][20][21][22] . ...
... Antidepressants are the most frequently prescribed drugs in the world, and among these, SSRIs are the most frequently prescribed 22,[24][25][26] . Although SSRIs have a good safety profile and tolerance 2 , well-known ocular side effects of SSRIs are mydriasis, elevated IOP, and acute angle closure glaucoma 3,4, [8][9][10][11][12][13][14][15][16][17] . Decreased visual acuity is reported to be the most common reason for patients to withdraw from studies on SSRI treatment 2,[27][28][29] . ...
Article
Full-text available
Purpose: To evaluate macular ganglion cell complex (GCC) thickness and peripapillary retinal nerve fiber layer (RNFL) thickness in patients treated with SSRIs. Methods: The present study included 62 eyes of 31 patients who were using SSRIs and 60 eyes of 30 healthy, age- and gender-matched control subjects. All patients underwent a full ophthalmological examination in which macular thickness, GCC thickness, and peripapillary RNFL thickness were measured using optical coherence tomography (OCT). The Mann–Whitney U test was used to compare the patients’ group with the age- and gender-matched control group. Pearson correlation analyses were also performed to assess the relationships between macular thickness, GCC thickness, RNFL thickness, and the duration of SSRI usage. Results: The mean duration of SSRI usage was 29.96 ± 27.19 (range 6–120) months. The foveal thickness was 253.48 ± 22.77µm in the patients’ group and 266.60 ± 20.64 µm in the control group; the difference between the groups was statistically significant. In addition, the perifoveal GCC thickness in the inferonasal and inferotemporal quadrant were significantly smaller thinner in the patient group (Mann–Whitney U test, p = 0.021and p = 0.013, respectively). Conclusions: Our results suggest a relation between SSRIs and decreased retinal GCC thickness and RNFL thickness. Future long-term prospective studies should elucidate the actual effect of SSRIs on GCC and RNFL thickness.
... The statistically significant p values are shown with bold characters. and the mechanism of the acute attack could not been completely ascertained 1,19 , most of them had predisposing factors as being elderly, female and hyperopic [12][13][14][15][16][17] . In all these case reports, the authors emphasized the role of passive mydriasis as precipitating event for occurring AACG. ...
... 5-HT7 receptors also induce mydriasis as stated previously 3,6,7 . On the other hand, the effect of serotonin on 5HT1A receptors leads to decrease in IOP 3,16 . The experimental studies seem to indicate that 5-HT1A agonists could become a new class of antiglaucoma drugs in a near future 26,27 . ...
Article
Full-text available
Purpose: To evaluate the short and long term effects of selective serotonin reuptake inhibitors (SSRIs) on intraocular pressure (IOP) and anterior segment parameters in open angle eyes. Materials and Methods: This cross-sectional study included 325 eyes of 166 subjects. Subjects were divided into three groups; group 1 included 116 eyes of 58 patients receiving SSRIs for 1 week - 6 months, group 2 included 102 eyes of 53 patients receiving SSRIs for longer than 6 months, and group 3 included 107 eyes of 55 healthy subjects not receiving any drugs. All of the patients receiving SSRIs were diagnosed as major depressive disorder. All groups were chosen to be similar in terms of age and gender. All patients underwent a detailed ophthalmologic examination including IOP measurement by Goldmann applanation tonometer and gonioscopy. Anterior segment parameters including pupil diameter (PD), central corneal thickness (CCT), anterior chamber depth (ACD), anterior chamber volume (ACV), and anterior chamber angle (ACA) were assessed by a Scheimpflug system. Results: Pupil diameter was significantly larger in patients receiving SSRIs for < 6 months and ≥ 6 months than control subjects (3.53 ± 0.71 mm, 3.48 ± 0.60 mm versus 3.11 ± 0.72 mm, p < 0.05) but this effect was independent from the duration of SSRI treatment. Intraocular pressure was significantly lower in patients receiving SSRIs for < 6 months and ≥ 6 months than control group (16.04 ± 2.17 mmHg, 16.11 ± 2.13 mmHg versus 17.34 ± 2.15 mmHg, p < 0.05) but there were no statistically significant differences between the patients receiving SSRIs for < 6 months and ≥ 6 months. There were no statistically significant differences between the patient and control group in values of CCT, ACD, ACV, and ACA. Anterior chamber angles were measured between 25° - 55° with Scheimpflug system and also classified as grade 3-4 (Shaffer system) by gonioscopy. Conclusions: Selective serotonin reuptake inhibitors cause mydriasis which is persistent during the treatment. In depression patients with open angle eyes, short and long term use of SSRIs leads to decrease in IOP.
... Patients under paroxetine therapy have reported ACG specific symptoms (i.e., loss of visual acuity or blurred vision) between 1 day and 4 months of treatment [51][52][53][54][55]. Interestingly, Sierra-Rodriguez et al. (2013) presented a case report of a unilateral visual loss due to chronic ACG under paroxetine treatment for 4 months. ...
Article
Full-text available
Through the years, the available psychopharmacological treatments have expanded with numerous new drugs. Besides weight gain, gastro-intestinal problems or Parkinson-like symptoms, ocular adverse effects of psychiatric drugs have been reported. These adverse effects are not common, but can be dangerous for the patient. This review summarises the current knowledge on the risk of raised intraocular pressure and glaucoma entailed by psychopharmacological treatment. Also, it provides updated data for clinicians involved in the treatment of patients with glaucoma or glaucoma risk factors. For this purpose, we performed an extensive literature search in the PubMed database using specific terms. Selective serotonin and noradrenaline reuptake inhibitors are the best evidenced as having no association with glaucoma. Antipsychotics, and especially first generation, seem to have no correlation with an increased intraocular pressure and therefore possibly with a risk of glaucoma, although a special attention should be paid when using ziprasidone. Tricyclic antidepressants, benzodiazepines and topiramate should be avoided in patients diagnosed with glaucoma or at risk. Clinicians should be aware of the possible psychotropic drug induced glaucoma and monitor at risk patients closely in order to prevent this condition. Irrespective of the psychopharmacological regimen taken into consideration, the glaucoma patient should be under the strict supervision of the ophthalmologist.
Article
This article provides a practical review of the diagnosis and management of angle closure induced by psychotropic agents, including tricyclic antidepressants, antipsychotics and anticonvulsants. Selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase inhibitors and antipsychotics may trigger angle closure by influencing pupil configuration through adrenergic, anticholinergic, serotonergic or dopaminergic mechanisms. Patients with narrow iridocorneal angles are at risk, and these are more common in people with hypermetropia (near-sightedness), older people and individuals with an Asian background. These patients may benefit from a laser peripheral iridotomy, either prophylactically or to relieve an acute angle-closure episode. An idiosyncratic reaction to medications such as topiramate may lead to angle closure through an alternate mechanism, leading to a uveal effusion. Ophthalmological review may be considered prior to commencing medications in high-risk patients.
Article
Purpose of the study: To report a novel case of drug-induced angle-closure from aripiprazole (Abilify), an atypical antipsychotic, and propose a mechanism for this association. Methods/results: We report a case of a 45 year-old Caucasian woman who presented in subacute angle closure two months after initiating aripiprazole 5 mg daily for depression. This patient reported no prior ocular history and had been on longstanding duloxetine (Cymbalta) 60 mg daily for over ten years prior to starting aripiprazole. Examination at initial presentation revealed an intraocular pressure (IOP) of 16 mm Hg in the right eye and an elevated IOP of 44 mm Hg in the left eye. Gonioscopy demonstrated a plateau iris configuration in the right eye and angle closure with a plateau iris configuration in the left eye. She was started on IOP-lowering therapy and underwent a laser peripheral iridotomy. Despite recommendation to discontinue aripiprazole, duloxetine was discontinued; aripiprazole was maintained and later increased to 10 mg daily for worsening depression. Three months after the dosage increase, the patient was found to have an elevated IOP of 32 mm Hg and angle-closure with a plateau iris configuration in the left eye. Iridoplasty was performed in the left eye with subsequent opening of the angle and improvement in IOP. The second attack of angle-closure led to the discontinuation of aripiprazole and a corresponding widening of the angles in both eyes one week after cessation. Conclusion: This is the first report to describe drug-induced angle closure glaucoma associated with aripiprazole use. The mechanism of angle closure, we hypothesize, is from mydriasis and/or supraciliary effusion mediated by the serotoninergic effect on the iris and ciliary body complex. Treatment is preferably cessation of the medication. However, in cases where the medication is necessary for management of major depression, iridoplasty should be performed to reduce the risk of angle closure.
Article
Full-text available
From the evidence available it is clear that melatonin and serotonin receptors exist in the iris/ciliary processes of the rabbit. These receptors may be involved in maintaining the intraocular pressure (IOP). However, the published results on this point are often contradictory, perhaps because of the variation in the species of animals used and the methodology employed. It is also clear that the data obtained from studies on the rabbit cannot be directly applied to man. Nevertheless, present information points to the possibility that drugs influencing specific serotonin and/or melatonin receptors may be used to influence IOP in man and thus have a therapeutic effect.
Article
Objective: To describe plateau iris syndrome associated with multiple neuroepithelial cysts of the pars plicata.Methods: Case reports of 3 patients with plateau iris syndrome who were found to have multiple bilateral ciliary body cysts on ultrasound biomicroscopic examination.Results: Ultrasound biomicroscopy revealed classic features of plateau iris syndrome in each patient but also showed multiple neuroepithelial cysts of the ciliary body in each eye.Conclusion: Plateau iris syndrome may be associated with multiple ciliary body cysts.
Article
A series of 16 cases of carotid-ophthalmic aneurysm treated by direct approach is reported and the following points are emphasized:– the aneurysm was associated with signs of optic nerve compression in half of the cases. – angiography did not always disclose the possibilities and the hazards of direct surgery. – indirect surgery (common carotid ligation) did not prevent the aneurysm from growing or restore useful vision. On the other hand, ligation of the aneurysmal neck or local trapping, where necessary, followed by removal of the aneurysm resulted in marked improvement of impaired vision. The hazard of ophthalmic artery occlusion is stressed.
Article
Ultrasound biomicroscopy is a new technique that uses high-frequency ultrasound (50 to 100 MHz) to produce images of the entire anterior segment at high resolution (20 to 50 microns). The iridocorneal angle, iris, ciliary body, and posterior chamber can be imaged in detail and the dimensions and anatomic relationships of these structures determined. Plateau iris syndrome is a condition in which the angle remains appositionally closed or occludable after iridectomy for angle-closure glaucoma. How the iris remains in a position that allows it to occlude the angle has been uncertain. We performed ultrasound biomicroscopy eye examinations on eight patients with clinically diagnosed plateau iris syndrome. In all the patients, ciliary processes were situated anteriorly compared to the position in normal subjects and in patients with angle closure caused by pupillary block. The ciliary processes provide structural support beneath the peripheral iris, preventing the iris root from falling away from the trabecular meshwork after iridectomy.
Article
Indalpine is a potent inhibitor of 5 HT uptake into central neurones with antidepressive properties; mydriasis is observed after a single oral dose of 25 mg. The miosis evoked by locally instilled pilocarpine is not modified by indalpine. There is a potentiation of the response of locally instilled adrenaline. It is suggested that indalpine has no anticholinergic effect. The potentiation of mydriasis evoked by adrenaline may reflect the blockade of the uptake of catecholamine into adrenergic nerve terminals.
Article
Major depression afflicts a significant percentage of the population, and optimum therapy is often limited by the poor tolerability and lethality in overdose of the tricyclic antidepressants. The selective serotonin reuptake inhibitors (SSRIs) fluoxetine, sertraline, and, more recently, paroxetine are viewed as welcome additions to existing therapy. The SSRIs are as effective as the tricyclic antidepressants, but are not associated with their adverse effect profile. Paroxetine in dosages of 20-50 mg/day is as effective as the older classic antidepressants, including amitriptyline, imipramine, and doxepin. It is effective in the elderly and in patients with recurrent, resistant, or severe depression.
Article
Serotonin (5-hydroxytryptamine, 5-HT) reduces forskolin-induced stimulation of cyclic AMP in rabbit iris-ciliary body (ICB) homogenates. The effect is dose dependent and can be mimicked by a number of 5-HT1 receptor agonists including 5-carboxamidotryptamine (5-CT) and RU 24969 [5-methoxy-3-(1,2,3,6, tetrahydro-4-pyridinyl)-1-indole]. The inhibitory effects of 5-CT and the 5-HT1A selective agent 8-hydroxy-2-(di-n-propyl-amino) tetralin (8-OH-DPAT) on forskolin stimulated adenylate cyclase activity are greater in isolated ciliary processes than in the iris musculature. Spiperone and propranolol significantly antagonize the action of 5-CT in the iris-ciliary body, while ketanserin (5-HT2 antagonist) and ICS 205930 (5-HT3/4 blocker) were without influence, indicating the presence of the 5-HT1A subtype of receptor. Studies carried out on human ICB homogenates also suggest the presence of 5-HT1A-like receptors, although these receptors are not identical to those in rabbit. Similarities include dose-dependent decreases in cAMP levels stimulated by forskolin elicited by 1-(3-chlorophenyl) piperazine (mCPP), 5-CT and 8-OH-DPAT. Moreover, the inhibitory effect of 5-CT can also be significantly reduced by the 5-HT1 receptor antagonist, propranolol. However, unlike the case of rabbit tissue, spiperone was ineffective in abolishing the 5-CT response in human ICB homogenates.
Article
To describe plateau iris syndrome associated with multiple neuroepithelial cysts of the pars plicata. Case reports of 3 patients with plateau iris syndrome who were found to have multiple bilateral ciliary body cysts on ultrasound biomicroscopic examination. Ultrasound biomicroscopy revealed classic features of plateau iris syndrome in each patient but also showed multiple neuroepithelial cysts of the ciliary body in each eye. Plateau iris syndrome may be associated with multiple ciliary body cysts.